Array BioPharma Assigned Patent
Copyright © Targeted News Service 2016
2016-10-06
ALEXANDRIA, Va., Oct. 6 -- Array BioPharma, Boulder, Colorado, has been assigned a patent (9,457,093) developed by eight co-inventors for "solid dispersions of a ERB2 (HER2) inhibitor." The co-inventors are David Shank Fry, Boulder, Colorado, Christopher M. Lindemann, Boulder, Colorado, Michael Preigh, Boulder, Colorado, Corey Jay Bloom, Boulder, Colorado, Christopher Donovan Craig, Boulder, Colorado, Devon Brevard Dubose, Boulder, Colorado, Jeff Gautschi, Boulder, Colorado, and Dan Smithey, Bou . . .